Back to 
BALYASNY ASSET MANAGEMENT L.P.
BALYASNY ASSET MANAGEMENT L.P.
APH
Showing 0 of 5 quarters
Position history for BALYASNY ASSET MANAGEMENT L.P.'s holdings in AMPIO PHARMACEUTICALS INC
No. Balyasny Asset Management exited its APH (Ampio Pharmaceuticals) position in Q3 2022. Its Q2 2022 13F listed 32,480 shares worth $5,000. Balyasny Asset Management first reported APH in Q1 2021 and held it in 3 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.